Invention Grant
- Patent Title: Heterodimeric antibodies that bind CD3 and CD38
-
Application No.: US17736475Application Date: 2022-05-04
-
Publication No.: US12129309B2Publication Date: 2024-10-29
- Inventor: Matthew Bernett , Gregory Moore , John Desjarlais , Seung Chu , Rumana Rashid , Umesh Muchhal
- Applicant: Xencor, Inc.
- Applicant Address: US CA Monrovia
- Assignee: Xencor, Inc.
- Current Assignee: Xencor, Inc.
- Current Assignee Address: US CA Pasadena
- Agency: Morgan, Lewis & Bockius, LLP
- Agent Sara E. Sims; Louis-Vu T. Nguyen
- The original application number of the division: US14952786 2015.11.25
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/18 ; C07K16/28 ; C07K16/30 ; A61K39/00
Abstract:
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Public/Granted literature
- US20220403049A1 HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38 Public/Granted day:2022-12-22
Information query
